Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
[Sphingosine-1-phosphate signaling system and the innovative mechanism of action of fingolimod in treatment of multiple sclerosis: review of foreign literature.]
IL-17-Induced Act1-Mediated Signaling Is Critical for Cuprizone-Induced Demyelination.
Mitochondrial changes within axons in multiple sclerosis: an update.
Synthetic lethality for linking the mycophenolate mofetil mode of action with molecular disease and drug profiles.
Natalizumab-related anaphylactoid reactions in MS patients are associated with HLA class II alleles.
Generation and characterization of spiking and non-spiking oligodendroglial progenitor cells from embryonic stem cells.
Longitudinal study of alexithymia and multiple sclerosis.
Reply to letter to the editor: "JC viremia and multiple sclerosis" by Focosi et al.
Molecular Dynamics of Multivalent Soluble Antigen Arrays Support Two-Signal Codelivery Mechanism in Treatment of Experimental Autoimmune Encephalomyelitis.
Early recognition and diagnosis of multiple sclerosis.
A double-blind, randomized, controlled study of botulinum toxin type A in MS-related tremor.
How safe could intrathecal transplantation of mesenchymal stem cells be considered in multiple sclerosis?-Reply.
A randomized, double-blind, phase 2 study of erythropoietin in optic neuritis.
Obstetrical epidural and spinal anesthesia in multiple sclerosis.
Bayesian inferences for beta semiparametric-mixed models to analyze longitudinal neuroimaging data.
Statins affect cell-surface expression of major histocompatibility complex class II molecules by disrupting cholesterol-containing microdomains.
Polymorphisms of paraoxonase 1 and 2 genes and the risk of multiple sclerosis in the Polish population.
HLA-DR15-derived self-peptides are involved in increased autologous T cell proliferation in multiple sclerosis.
What do people with MS want from a web-based resource to encourage increased physical activity behaviour?
Identifying the Start of Multiple Sclerosis Injury: A Serial DTI Study.
Demyelinating disease in SLE: Is it multiple sclerosis or lupus?
Minocycline attenuates experimental autoimmune encephalomyelitis in rats by reducing T cell infiltration into the spinal cord.
Previous treatment influences fingolimod efficacy in relapsing-remitting multiple sclerosis: results from an observational study.
The Symbol Digit Modalities Test as sentinel test for cognitive impairment in multiple sclerosis.
Effects of IFN-beta, leptin and simvastatin on LIF secretion by T lymphocytes of MS patients and healthy controls.
Pages
« first
‹ previous
…
246
247
248
249
250
251
252
253
254
…
next ›
last »